Organised by the European Society of Cardiology, ESC Congress 2026 took place in Munich, Germany, from 28–31 August, bringing together cardiovascular science and clinical practice through a programme of scientific presentations, Hot Line sessions, and Late-Breaking Science sessions.
In this congress interview, Dr. Himanshu Rai is asked about a meta-analysis, whether Lp(a) should be routinely measured before elective PCI, and whether Lp(a)-lowering therapies could have a role in preventing in-stent restenosis.
Dr. Himanshu Rai is Head of the Imaging Core Laboratory at the Cardiovascular Research Institute Dublin, Mater Private Hospital, and Honorary Clinical Lecturer at the Royal College of Surgeons in Ireland. Dr. Rai’s research background includes coronary artery disease genetics and intravascular imaging.
Key highlights from this clip:
● The research presented in the congress meta-analysis.
● Lp(a) as a focus of research into in-stent restenosis.
● Whether RNA-targeted Lp(a)-lowering therapies could help reduce restenosis risk.
● Whether the findings support routine Lp(a) measurement before elective PCI.
● The question of translating meta-analysis findings into clinical practice.
This video is intended for medical education and professional discussion.